Zum Inhalt der Seite gehen
Research Digest 114

https://www.emerge.org.au/researchdigest/research-digest-issue-114/

Includes new "Easy Read Overview" plus the option to hear the text

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
@mecfs
#MyalgicEncephalomyelitis #ChronicFatigueSyndrome #MEcfs #CFS #PwME
11:04 am February 28, 2025 Research Digest | Issue 114 The 114th edition of the Research Digest covers studies on potential treatments, biomarkers, and risk factors for long COVID and ME/CFS. Highlights include intravenous immunoglobulin as a possible therapy, biomarkers distinguishing long COVID patients with ME/CFS symptoms, a large paediatric study on risk factors and recovery, and a review of microRNAs in disease mechanisms. We also feature Australian research linking brain changes to cognitive symptoms, reinforcing the biological basis of these conditions. Contributing Digesters: Jyothsna, Solène, Sarah, Shan and Simone. Don’t forget about the new addition to the Research Digest!! In response to recent feedback from our community, we’ve introduced the Easy Read Overview. Placed before each article’s summary, the Easy Read Overview gives readers a short, two- to three-sentence overview, providing a quick snapshot of the research, making it even easier to stay informed. We hope you find the Easy Read Overview and the recently added audio summaries (below), valuable features of Emerge Australia’s Research Digest.
#cfs #LongCovid #mecfs #pwme #PostCovid #PASC #LongHaulers #MyalgicEncephalomyelitis #chronicfatiguesyndrome #pwlc #PostCovid19 #lc #covidlonghaulers #postcovidsyndrome #covidbrain #neuropasc @MECFS group @longcovid group
⇧